why choose us

Clinical Trials Search

Showing 15,110 of 132,656 result(s)
A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms

Status: Completed

Condition: Relapsed or Refractory Acute Myeloid Leukemia

Interventions: Monoclonal antibody specific for LAIR-1

Date: 2023-02-08

Use of Ritual Epost Postnatal Multivitamins During the Postpartum Period

Status: NOT_YET_RECRUITING

Condition: Lactation Disorder - Postpartum Condition or Complication

Interventions: The Ritual Epre supplement is a commercially available multivitamin-mineral supplement designed for pregnant and lactating women.

Date: 2023-02-08

Anti-Inflammatory Challenge in Schizophrenia

Status: NOT_YET_RECRUITING

Condition: Schizophrenia

Interventions:

Infliximab has FDA approval for the treatment of rheumatoid arthritis and inflammatory bowel syndrome.
The current proposal represents the use

Date: 2023-02-08

Empower@Home:Connected - Feasibility and Preliminary Effect Study

Status: COMPLETED

Condition: Depression

Interventions: Cognitive behavioral therapy

Date: 2023-02-08

TRUDI: TDXD+Durva in HER2+;Low IBC

Status: Completed

Condition: Invasive Breast Cancer

Interventions: via IV, protocol determined dosage once per cycle up to eight cycles.
Each cycle will last for 21 days (three weeks).

Date: 2023-02-08

VitD3 Supplementation in Patients With Multiple Myeloma

Status: NOT_YET_RECRUITING

Condition: Multiple Myeloma

Interventions: For first three cycles, taken orally once daily for 28 days at 10mg;day dose.
After cycle 4, taken orally once daily at 15 mg;day dose

Date: 2023-02-08

RP2;RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC

Status: ACTIVE_NOT_RECRUITING

Condition: Refractory Metastatic Colorectal Cancer

Interventions: Genetically modified herpes simplex type 1 virus

Date: 2023-02-08

Longitudinal Study for Central Nervous System Vasculitis

Status: Completed

Condition: Central Nervous System Vasculitis

Interventions:

Date: 2023-02-08

A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems

Status: COMPLETED

Condition: Liver Diseases

Interventions: BI 690517

Date: 2023-02-08